ACHL
Achilles Therapeutics PLC ADR
NASDAQ: ACHL · HEALTHCARE · BIOTECHNOLOGY
$1.48
+0.00% today
Updated 2026-04-29
Market cap
$63.22M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.66
Dividend yield
—
52W range
$0 – $0
Volume
1.2M
Achilles Therapeutics PLC ADR (ACHL) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Operating cash flow | $-7598.00 | $-14.14M | $-25.25M | $-59.28M | $-59.53M | $-48.45M |
| Capital expenditures | $258.00 | $942000.00 | $11.85M | $7.63M | $7.51M | $1.10M |
| Depreciation | — | — | — | — | — | — |
| Stock-based comp | $76.00 | $719000.00 | $2.99M | $6.32M | $7.02M | $6.36M |
| Free cash flow | $-7856.00 | $-15.08M | $-37.10M | $-66.92M | $-67.05M | $-49.55M |
| Investing cash flow | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — |